Partner news
News
Partner news
The UK’s largest ever health research programme to transform the prevention, detection and treatment of diseases
Read full storyPartner news
Philogen announces new collaboration with Janssen to discover small molecule therapeutics
Read full storyPartner news
Ultromics Announces Collaboration with Janssen to Develop AI for Patients with Amyloidosis with Cardiac Involvement
Read full storyPartner news
F-star Therapeutics Announces License Agreement with Janssen to Develop and Commercialize Multiple Next Generation Bispecific Antibody Therapeutics
Read full storyPartner news
Whole Genome Sequencing data on 200,000 UK Biobank participants are made widely available for research
Read full storyPartner news
Apollo Therapeutics Completes $145 Million Financing Led by Patient Square Capital to Expand and Advance Portfolio-Based Drug Development
Read full storyPartner news
Mestag Therapeutics announces collaboration with Janssen, focused on the discovery of novel fibroblast targets for the treatment of inflammatory disease
Read full storyPartner news
L'engagement de Janssen France dans l'IA et la génomique
Read full storyPartner news
Oxford to collaborate with Janssen to map the cellular landscape of immune mediated disorders
Read full storyPartner news
Exonate announces the initiation of Phase Ib/II clinical trial for Diabetic Macular Oedema, as part of its collaboration with Janssen
Read full storyPartner news
£10 million research collaboration to detect lung cancer earlier
Read full storyPartner news
Revitope Oncology Announces Strategic Collaboration with Janssen to Leverage its Unique T Cell Engager Platform
Read full storyPartner news
Morphic Expands Research and Development Collaboration with Janssen Through Third Integrin Program
Read full storyPartner news